ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2724

cAMP Responsive Element Modulator (CREM)α Governs CD8 Expression and Contributes to the Generation of CD3+CD4–CD8– T Cells in Lupus

Christian M. Hedrich1, José C. Crispín1, Thomas Rauen1, Christina Ioannidis1, Tomohiro Koga2, Noe Rodriguez Rodriguez2, Sokratis A. Apostolidis3, Vasileios C. Kyttaris2 and George C. Tsokos1, 1Medicine/Rheumatology, BIDMC, Harvard Medical School, Boston, MA, 2Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epigenetics, inflammation and transcription factor, SLE, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: 2013 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lectureship

Session Type: Abstract Submissions (ACR)

Background/Purpose: CD3+CD4–CD8– “double negative” T cells are expanded in the peripheral blood of patients with systemic lupus erythematosus (SLE) and lupus-prone mice. Double negative T cells infiltrate tissues, induce immunoglobulin production and secrete pro-inflammatory cytokines. Although double negative T cells have been claimed to derive from CD8+ T cells through down-regulation of CD8 surface co-receptors, the molecular mechanisms orchestrating this process remain unclear. The transcription factor cAMP responsive element modulator (CREM)α, that is overexpressed in T cells from SLE patients, has been demonstrated to trans-regulate lupus-relevant genes and orchestrate epigenetic remodeling in mature T cells. Thus, CREMα is a promising candidate in the search for molecular mechanisms in T cell pathology in SLE.

Methods: Primary human and murine T lymphocytes were isolated to assess epigenetic differences of the CD8 cluster in CD8+, CD4+, and double negative T cells using MeDIP and ChIP techniques. CD8 mRNA and protein expression was monitored in response to forced expression or knock-down of CREMα. CREMα-mediated effects on chromatin conformation were assessed using over-expression and knock-down techniques, followed by MeDIP or ChIP. Interactions between CREMα and epigenetic modifiers were established using Co-IPs and proximity ligation assays (PLA).

Results: We link CREMα with transcriptional silencing of CD8A and CD8B in T cells from SLE patients and lupus prone MRL/lpr mice. CREMα trans-represses CD8 and mediates chromatin remodeling of the CD8 cluster through the recruitment of DNA methyltransferase (DNMT)3a and histone methyltransferase G9a.

Conclusion: We conclude that CREMα is essential for the expansion of double negative T cells in SLE and propose that CREMα may be utilized as disease biomarker and therapeutic target.

Description: Macintosh HD:Users:chedrich:Desktop:ACR Abstract 2013.tif

An interaction between CREMα and G9a has been established applying proximity ligation assays. Ex vivo isolated CD8+ T cells exhibit interactions between CREMα and G9a that are enhanced after TCR-stimulation (120h). Nuclei are stained with DAPI, green signals represent CREMα:G9a interactions.


Disclosure:

C. M. Hedrich,
None;

J. C. Crispín,
None;

T. Rauen,
None;

C. Ioannidis,
None;

T. Koga,
None;

N. Rodriguez Rodriguez,
None;

S. A. Apostolidis,
None;

V. C. Kyttaris,
None;

G. C. Tsokos,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/camp-responsive-element-modulator-crem%ce%b1-governs-cd8-expression-and-contributes-to-the-generation-of-cd3cd4cd8-t-cells-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology